Synartro AB
556866-4220ActiveDeveloping sustained local injection treatments for osteoarthritis pain relief.
Clinical Stage Life Science Companysynartro.com
Yleiskatsaus
- 1–4
- Työntekijät
- ≤1t SEK
- Liikevaihto
- 2011
- Perustettu
Avainpäättäjät
Magnus Hurst
CFO & acting CEO
@synartro.com+46760XXXXXX
Antonio Bermejo Gómez
Chief Development Officer
@synartro.com+46760XXXXXX
Mats Persson
Board Member
@synartro.com
Maria Nyhage
Board Member
@synartro.com
+2 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Synartro AB is a clinical stage Swedish life science company focused on developing novel local injection treatments for osteoarthritis (OA). Their core innovation lies in a patented technology that chemically binds existing, proven drugs to a base compound. This process enables sustained drug releas...
REGENARTI AS